Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know?

Eur Cardiol · 2025 · PMC12042294 · PMID 40309220

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

failed to reach statistical significancep=0.064so close (0.05 < p ≤ 0.1)

27 Of note, the treatment benefit of GLP-1 RAs was numerically higher in diabetes patients with ASCVD (15% versus 6%) but p for interaction failed to reach statistical significance (p=0.064).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.